-
In Search For Alzheimer's Drugs, Researchers Must Go Beyond Beta Amyloid
STAT | In the search for Alzheimer's drugs, it's time to pay more attention to drugs that go beyond targeting beta amyloid, a protein linked to the disease.
Nov 17, 2017
-
African scientists get their own open-access publishing platform
Nature News & Comment | Venture will launch next year and seeks to strengthen continent's science by helping academics share work more quickly.
Nov 15, 2017
-
US Scientists Try 1st Gene Editing In The Body
AP News | Scientists for the first time have tried editing a gene inside the body in a bold attempt to permanently change a person's DNA to cure a disease.
Nov 15, 2017
-
Illumina Grows Clinical IVD Portfolio With Introduction Of NextSeq 550Dx And Expanded Use Of MiSeqDx
Bio-IT World Brief | Illumina announced today the introduction of its NextSeq 550Dx instrument and the updated use of its MiSeqDx instrument, expanding Illumina’s diagnostic NGS product portfolio capable of covering a broad range of clinical applications to serve almost any clinical lab need for NGS-based in vitro diagnostic products.
Nov 15, 2017
-
Genomics’ Role In Global Pathogen Surveillance, Diagnosis
Bio-IT World | A recent Nature Reviews Genetics article explores the steps moving us toward a genomics-informed, real-time, global pathogen surveillance system, and the need for such progress.
Nov 14, 2017
-
Wiping Out Alzheimers Is Personal To Microsofts Bill Gates And Paul Allen
Forbes | Bill Gates announced today that he will invest $50 million of his own money in the Dementia Discovery Fund. Gates has a different approach to funding Alzheimer's research than does Allen, his Microsoft co-founder, but the two are similar in their motives and beliefs about what it's going to take to conquer the disease.
Nov 13, 2017
-
America Just Can’t Match China’s Exploding Supercomputing Power
MIT Technology Review | What's up in emerging technology, including China's exploding supercomputing power.
Nov 13, 2017
-
Transforming Information Into Knowledge In The Big Data Era
Bio-IT World Contributed Commentary | Despite the overwhelming volume and complexity of scientific literature, and the myriad ways of accessing and managing it, the success of an entire research organization may depend on quick, efficient, cost-effective, and unfettered access to the information contained in reference publications. So, how do biomedical and drug discovery researchers effectively transform information into useful knowledge in the Big Data era?
Nov 13, 2017
-
Struggling GSK Recruits Cancer Drug Guru Hal Barron As Its New R&D Chief
ENDPOINTS | GlaxoSmithKline has recruited Hal Barron, one of the world's top cancer drug investigators, to take the helm of its troubled pharma R&D group, offering a fresh sign that the pharma giant is jumping back in a big way into oncology.
Nov 9, 2017
